Skip to content

会社情報, ヘルスケア, イルミナ社員, コミュニティー, がん研究, 複雑な疾患ゲノム, 創薬ゲノム, Immuno-Oncology Research, Immunology, ライフサイエンス, Oncology, Reproductive Health

Video: Francis deSouza Speaks at the 16th Annual Precision Medicine World Conference

A discussion about the current and future state of genomics with Twist Bioscience’s Emily Leproust

Francis deSouza Speaks at the 16th Annual Precision Medicine World Conference
2019/02/13

Recently, Francis de Souza, President and CEO of Illumina, Inc. spoke at the Personalized Medicine World Conference in Silicon Valley to discuss the adoption of clinical genomics, the future of genomics and how Illumina is helping advance science, transform medicine, and impact lives. He was interviewed by Emily Leproust, Ph.D., CEO of Twist Biosciences, who was an early pioneer in high-throughput synthesis and DNA sequencing.

Genomics is going to have the most profound impact of anything I've seen in my lifetime.

*Photo courtesy of Precision Medicine World Conference

Recent Articles

Project Baby Bear – California Pilots Public Health Coverage for WGS
Project Baby Bear – California Pilots Public Health Coverage for WGS
Knowledge is Power: Unlocking the Potential of the Genome
Knowledge is Power: Unlocking the Potential of the Genome
Illumina Accelerator Invests in Four Startups for Ninth Cycle
Illumina Accelerator Invests in Four Startups for Ninth Cycle